The involvement of multiple thrombogenic and atherogenic markers in premature coronary artery disease
OBJECTIVE: To examine the association of atherogenic and thrombogenic markers and lymphotoxin-alfa gene mutations with the risk of premature coronary disease. METHODS: This cross-sectional, case-control, age-adjusted study was conducted in 336 patients with premature coronary disease (<50 years...
Main Authors: | Antonio P. Mansur, Julio Y. Takada, Celia M. C. Strunz, Solange D. Avakian, Luiz Antonio M. Cesar, Jose A.F. Ramires |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier España
2013-12-01
|
Series: | Clinics |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322013001201502&lng=en&tlng=en |
Similar Items
-
Association of lipoprotein(a) with platelet aggregation and thrombogenicity in patients undergoing percutaneous coronary intervention
by: Pei Zhu, et al.
Published: (2021-07-01) -
Effect of lymphotoxin blockage on different stages of Sjogren's syndrome in an animal model
by: Alexander Jacob, et al.
Published: (2022-06-01) -
Promising roles of erythropoietin and lymphotoxin alpha in critical illness: A pilot study in critically ill children
by: Seham A. EL Sherbini, et al.
Published: (2018-03-01) -
Relationship between atherogenic index of plasma and stent thrombosis in patients with acute coronary syndrome
by: Özge Özcan Abacıoğlu, et al.
Published: (2022-02-01) -
Effects of electret coating technology on coronary stent thrombogenicity
by: M. Urooj Zafar, et al.
Published: (2022-02-01)